Katja Hönzke

SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals

Nils C. Gassen, Jan Papies, Thomas Bajaj et al. · Nature Communications · 2021 · 282 citations · Full text

Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy

Emanuel Wyler, Kirstin Mösbauer, Vedran Franke et al. · iScience · 2021 · 281 citations · Full text

Inflammatory Lung Disease, Transcriptomic Profiling, Lung Inflammation +18

Phage capsid nanoparticles with defined ligand arrangement block influenza virus entry

Daniel Lauster, Kai Ludwig, Saba Nojoumi et al. · Nature Nanotechnology · 2020 · 125 citations · Full text

Nanoparticles, Engineering, Virology +5

Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages

Katja Hönzke, Benedikt Obermayer, Christin Mache et al. · European Respiratory Journal · 2022 · 58 citations · Full text

Antiviral potential of human IFN-α subtypes against influenza A H3N2 infection in human lung explants reveals subtype-specific activities

Aline da Rocha Matos, Katharina Wunderlich, Sebastian Schloer et al. · Emerging Microbes & Infections · 2019 · 44 citations · Full text